Avid Bioservices Inc (CDMO)

[biopharm]

...hard to say anything about the phase IIb trial data? I hope you cancel explain and halt all progress of the BP who is possibly going to fork over big $$$$ for upfront payment to Peregrine....they will be saving lots of money ....unless they find it critical that the MOS is the bottomline that patients are concerned about to extend their life longer than any other treatment that is FDA approved as of now to : )

Lets just say the the FDA will be basing their approval with much...much....many mucho much more on MOS than what you are concerned with.

I guess we will all find out over the next three months!

Good luck to those on both sides of the fence : )